Join to view full profile
9609 Medical Center DriveBuilding 9609 MSC 9760Bethesda, MD 20892
Phone+1 240-781-3300
Dr. Sharpless is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1996 - 2000
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1993 - 1996
University of North Carolina at Chapel Hill School of MedicineClass of 1993
Certifications & Licensure
NC State Medical License 2002 - 2018
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2008
Clinical Trials
Publications & Presentations
PubMed
- Innovate or Be Left Behind: A Path to Prospective External Control Arms for Accelerated Oncology Drug Development.Stephen M Hahn, Norman E Sharpless, Christer Svedman, William B Capra, Mark Lee
Journal of Clinical Oncology. 2026-08-05 - 4 citationsA Threat to Evidence-Based Vaccine Policy and Public Health Security at the FDA.Robert M Califf, Andrew C von Eschenbach, Michael A Friedman, Brett P Giroir, Scott Gottlieb
The New England Journal of Medicine. 2026-01-01 - Bridging the Gap in Cancer Clinical Trial Funding.Yara Abdou, Norman E Sharpless
Journal of Clinical Oncology. 2024-11-20
Authored Content
- Better Together: Developing New Collaborations for Cancer ResearchJanuary 2022
Press Mentions
Joseph Fraumeni, 93, Dies; Helped Discover Genetic Link to CancerJuly 9th, 2026- From No Hope to a Potential Cure for a Deadly Blood CancerJune 3rd, 2025
- Blood Test Gives Breast Cancer Patients Early Warning of Faltering DrugsJune 1st, 2025
Grant Support
- In Vivo Murine Models Of Metastasis For Therapeutic TestingNational Cancer Institute2012
- UNC Oncology Clinical Translational Research Training ProgramNational Cancer Institute2011
- Murine &Human In Vivo Models Of Melanoma FormationNational Institute Of Environmental Health Sciences2007–2011
- The Role Of P16INK4A In Mammalian AgingNational Institute On Aging2004–2011
- Melanoma In P16INK4A And P19ARF Deficient MiceNational Cancer Institute2002–2006
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
